Groowe Groowe / Newsroom / NVO
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

NVO News

Novo-Nordisk A/S

Graph AI Raises $13.3M Series A to Scale the First AI-Native Operating System for Patient Safety

prnewswire.com
NVDA GOOG MSFT AMZN META IBM ORCL CRM ADBE INTC AMD QCOM AMAT MU SMCI ASML LRCX KLAC TER SNPS CDNS PANW CRWD DDOG PLTR SNOW AI UPST SOFI COIN RIOT MARA PLUG FCEL ROKU NFLX DIS CMCSA TCOM BABA JD PDD NIO LI TSLA RIVN LCID GM F STLA VWAGY HON GE BA LMT RTX GD NOC AVAV KBR BWXT XOM CVX SHEL BIDU NET FTNT CSCO HPQ DELL LEN DHI NVR PHM TMHC MTH KBH BKH ESNT MTG WFG RGA AGNC TWO PSEC ARCC BX KKR APO CME ICE MSCI SPGI EQIX AMKR WDC SE MELI AMGN GILD BMY PFE MRK LLY ABBV REGN VRTX BIIB AZN SNY NVS ROG TEVA BHC ALKS IRTC EXAS CRIS EDIT NTLA BNTX MRNA ALNY BTAI NVO LULU SIRI SPOT PTON GOOGL ZS XPEV

Zifo Co-Launches REAL 2026 to Spotlight the Next Generation of Connected, AI-Enabled Lab Environments

prnewswire.com
NVO MRK BTAI

CRB Names Helga Margrethe Salling Chief Growth Officer

globenewswire.com
J NVO

2026 Obstructive Sleep Apnea (OSA) Competitive Landscape and Clinical Trial Analysis - 18+ Companies Advance New OSA Therapies

globenewswire.com
LLY APMD AMGN NVO

ContentCon 2026: Every Brand Now Has Two Audiences, Humans and Agents

globenewswire.com
ALGT PHG MASS WMT MDLZ SSTK SMCI NVDA MSFT GOOG AMZN META IBM CRM ADBE INTC AMD MU QCOM PANW SNPS CDNS ASML AMAT LRCX KLAC TER NXPI ON AEHR PLTR AI UPST SOFI COIN MARA RIOT PLUG FCEL BE EXAS REGN GILD BIIB CRSP ROKU NFLX DIS CMCSA TTD SNOW DDOG ZS CRWD OKTA SMTC MCHP ADI TXN MRVL ALGN CTAS PAYX ADP CVS UNH AMGN LLY PFE MRK JNJ BMY ABBV VRTX AZN NVO SNY XOM CVX SRE NEE DUK SO PCG ED AEP ETR WEC D NI EXC NRG CEG IRBT GOOGL

Complement 3 Glomerulopathy (C3G) Market Analysis Report 2026-2036 | Complement 3 Glomerulopathy Market Forecast to Reach Approximately $1 Billion by 2036 as Targeted Therapies Transform C3G Treatment

globenewswire.com
NVS APLS NVO OMER ARWR

Novo Nordisk A/S - share repurchase programme

globenewswire.com
NVO

Novo Nordisk STEP Young phase 3 data: 40.4% of children living with obesity achieved a BMI below the obesity threshold with semaglutide and lifestyle modification

globenewswire.com
NVO

2026 RNAi Therapeutics Market Report (3rd Edition): Analysis by Type of RNAi Molecule, Therapeutic Area, Route of Administration, Key Geographical Regions, Sales Forecast and Leading Industry Players to 2035

globenewswire.com
ALNY ARWR NVO NVS BIIB REGN GILD MRK BMY ABBV AMGN AZN PFE SNY TEVA BHC CRSP EDIT NTLA SRPT SLN

GLP-1 Use Among Young Children With Obesity in US Remains Rare but Is Rising Rapidly

prnewswire.com
NVO LLY SNY AZN MRK BMY MDT